Literature DB >> 23498648

Neutrophil dysfunction varies with the stage of canine visceral leishmaniosis.

B F M Almeida1, L G Narciso, A M Bosco, P P Pereira, E T Braga, S V Avanço, M Marcondes, P C Ciarlini.   

Abstract

Canine visceral leishmaniosis (CVL) causes a dependent-stage alteration in neutrophil oxidative metabolism. When production of reactive oxygen species (ROS) exceeds the antioxidant capacity of neutrophils, apoptosis is triggered, impairing the viability and function of these cells, which can predispose dogs to infection. However, the uremic condition observed in late-stage CVL can also alter the viability and function of human neutrophils. To more clearly understand this relationship, the apoptosis rate and oxidative metabolism of neutrophils from control dogs (n=20) were compared to dogs in moderate (n=15) and very severe (n=15) stage CVL, classified according to LeishVet Consensus. To assess neutrophil oxidative metabolism, superoxide production was measured using the nitroblue tetrazolium reduction test (NBT) in isolated neutrophils. The apoptosis rate of neutrophils was estimated using the morphological method. Moderate-stage dogs presented increased superoxide production, while dogs with very severe stage CVL presented decreased superoxide production and an increase neutrophil apoptosis rate. Leishmaniosis causes differential neutrophil dysfunction according to disease stage. In moderate stage CVL, increased superoxide production is observed with no change in neutrophil viability. However, in very severe stage CVL, decreased superoxide production and increased apoptosis occur associated with uremia.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Leishmania spp.; Oxidative metabolism; Polymorphonuclear

Mesh:

Year:  2013        PMID: 23498648     DOI: 10.1016/j.vetpar.2013.02.016

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  6 in total

Review 1.  Permissive and protective roles for neutrophils in leishmaniasis.

Authors:  E D Carlsen; Y Liang; T R Shelite; D H Walker; P C Melby; L Soong
Journal:  Clin Exp Immunol       Date:  2015-08-28       Impact factor: 4.330

Review 2.  The balancing act: Immunology of leishmaniosis.

Authors:  Angela J Toepp; Christine A Petersen
Journal:  Res Vet Sci       Date:  2020-02-11       Impact factor: 2.534

Review 3.  Biomarkers Associated With Leishmania infantum Exposure, Infection, and Disease in Dogs.

Authors:  Carla Maia; Lenea Campino
Journal:  Front Cell Infect Microbiol       Date:  2018-09-06       Impact factor: 5.293

Review 4.  Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.

Authors:  Greta Volpedo; Thalia Pacheco-Fernandez; Parna Bhattacharya; Timur Oljuskin; Ranadhir Dey; Sreenivas Gannavaram; Abhay R Satoskar; Hira L Nakhasi
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

5.  Insights on adaptive and innate immunity in canine leishmaniosis.

Authors:  Shazia Hosein; Damer P Blake; Laia Solano-Gallego
Journal:  Parasitology       Date:  2016-04-20       Impact factor: 3.234

6.  Assessment of Leishmania infantum infection in equine populations in a canine visceral leishmaniosis transmission area.

Authors:  Taiane Acunha Escobar; Gabriela Dowich; Thália Pacheco Dos Santos; Luísa Zuravski; Claudia Acosta Duarte; Irina Lübeck; Vanusa Manfredini
Journal:  BMC Vet Res       Date:  2019-10-30       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.